Log in
Enquire now
‌

US Patent 8946405 Controlled release from solid supports

Patent 8946405 was granted and assigned to ProLynx on February, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
‌
ProLynx
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
89464050
Patent Inventor Names
Daniel V. Santi0
Gary Ashley0
Date of Patent
February 3, 2015
0
Patent Application Number
136963000
Date Filed
May 5, 2011
0
Patent Citations Received
‌
US Patent 11970583 Therapeutic dendrimer
0
‌
US Patent 11857603 PTH compounds with low peak-to-trough ratios
0
‌
US Patent 11890326 Controlled-release PTH compound
0
‌
US Patent 11879001 Conjugate comprising an IL-2 moiety
0
‌
US Patent 11918628 Controlled-release PTH compound
0
‌
US Patent 12083182 Controlled-release CNP agonists with increased NEP stability
0
‌
US Patent 12071517 Therapeutic dendrimer
0
‌
US Patent 11759504 PTH compounds with low peak-to-trough ratios
Patent Primary Examiner
‌
Brandon Fetterolf
0
Patent abstract

The invention relates to solid supports useful in medical applications that provide controlled release of drugs, such as peptides, nucleic acids and small molecules. The drugs are covalently coupled to the solid support through a linkage that releases the drug or a prodrug through controlled beta elimination.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8946405 Controlled release from solid supports

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us